Protagonist Therapeutics
PTGX
#2241
Rank
NZ$15.11 B
Marketcap
NZ$231.60
Share price
2.00%
Change (1 day)
55.31%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): NZ$2.20

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$2.22. In 2025 the company made an earnings per share (EPS) of NZ-$3.73 a decrease over its 2024 EPS that were of NZ$8.16.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.20-158.8%
2025NZ-$3.73-145.76%
2024NZ$8.16-402.7%
2023NZ-$2.70-43.08%
2022NZ-$4.74-3.7%
2021NZ-$4.9235%
2020NZ-$3.64-33.33%
2019NZ-$5.4674.42%
2018NZ-$3.13-20.74%
2017NZ-$3.95-45.64%
2016NZ-$7.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.46-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA